 | • レポートコード：QAF27726 • 出版社/出版日：QYResearch / 2021年4月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のヒドロキシカルバミド市場について種類別（カプセル、タブレット）、用途別（鎌状赤血球症、がん、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ヒドロキシカルバミド市場の概要 ・世界の主要地域別ヒドロキシカルバミド市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のヒドロキシカルバミド市場規模2016-2021：種類別（カプセル、タブレット） ・世界のヒドロキシカルバミド市場予測2012-2027：種類別（カプセル、タブレット） ・世界のヒドロキシカルバミド市場規模2016-2021：用途別（鎌状赤血球症、がん、その他） ・世界のヒドロキシカルバミド市場予測2012-2027：用途別（鎌状赤血球症、がん、その他） ・ヒドロキシカルバミドのアメリカ市場規模と予測2016-2021 ・ヒドロキシカルバミドのヨーロッパ市場規模と予測2016-2021 ・ヒドロキシカルバミドの中国市場規模と予測2016-2021 ・ヒドロキシカルバミドの日本市場規模と予測2016-2021 ・ヒドロキシカルバミドの東南アジア市場規模と予測2016-2021 ・ヒドロキシカルバミドのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Bristol Myers Squibb、Taj Pharma、Beijing Jialin Pharma、Qilu Pharmaceutical、Teva Pharma、Cipla、Zydus Cadila、United Biotech、Par Pharma、Khandelwal Laboratories、Alkem (Cytomed)、Samarth Pharma、VHB Life Sciences） ・ヒドロキシカルバミドの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ヒドロキシカルバミドの市場動向・機会・課題 ・調査の結論 |
Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth.
Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the baby. Hydroxycarbamide is in the antineoplastic family of medications. It is believed to work by blocking the making of DNA.
The classification of Hydroxycarbamide includes capsule and tablet, and the proportion of capsule in 2016 is about 63%, and the proportion is in decreasing trend from 2012 to 2016.
Hydroxycarbamide is widely used for sickle cell disease, cancer and other disease. The most proportion of Hydroxycarbamide is used for sickle cell disease, and the proportion in 2016 is 45%.
Asia Pacific is the largest supplier of Hydroxycarbamide, with a production market share nearly 59% in 2016.
Middle East and Africa is the largest consumption place, with a consumption market share nearly 36% in 2016. Following Middle East and Africa, Asia Pacific is the second largest consumption place with the consumption market share of 20%.
Market competition is not intense. Bristol Myers Squibb, Taj Pharma, Beijing Jialin Pharma, Qilu Pharmaceutical, Teva Pharma, Cipla, Zydus Cadila, United Biotech, Par Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Hydroxycarbamide Market
The global Hydroxycarbamide market was valued at US$ 235.7 in 2020 and will reach US$ 326.8 million by the end of 2027, growing at a CAGR of 5.6% during 2022-2027.
Global Hydroxycarbamide Scope and Market Size
The global Hydroxycarbamide market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hydroxycarbamide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Capsule
Tablet
Segment by Application
Sickle Cell Disease
Cancer
Others
The Hydroxycarbamide market is analysed and market size information is provided by regions (countries). Segment by Application, the Hydroxycarbamide market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Bristol Myers Squibb
Taj Pharma
Beijing Jialin Pharma
Qilu Pharmaceutical
Teva Pharma
Cipla
Zydus Cadila
United Biotech
Par Pharma
Khandelwal Laboratories
Alkem (Cytomed)
Samarth Pharma
VHB Life Sciences
1 Hydroxycarbamide Market Overview
1.1 Hydroxycarbamide Product Scope
1.2 Hydroxycarbamide Segment by Type
1.2.1 Global Hydroxycarbamide Sales by Type (2016 & 2021 & 2027)
1.2.2 Capsule
1.2.3 Tablet
1.3 Hydroxycarbamide Segment by Application
1.3.1 Global Hydroxycarbamide Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Sickle Cell Disease
1.3.3 Cancer
1.3.4 Others
1.4 Hydroxycarbamide Market Estimates and Forecasts (2016-2027)
1.4.1 Global Hydroxycarbamide Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Hydroxycarbamide Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Hydroxycarbamide Price Trends (2016-2027)
2 Hydroxycarbamide Estimates and Forecasts by Region
2.1 Global Hydroxycarbamide Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Hydroxycarbamide Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Hydroxycarbamide Sales Market Share by Region (2016-2021)
2.2.2 Global Hydroxycarbamide Revenue Market Share by Region (2016-2021)
2.3 Global Hydroxycarbamide Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Hydroxycarbamide Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Hydroxycarbamide Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Hydroxycarbamide Estimates and Projections (2016-2027)
2.4.2 Europe Hydroxycarbamide Estimates and Projections (2016-2027)
2.4.3 China Hydroxycarbamide Estimates and Projections (2016-2027)
2.4.4 Japan Hydroxycarbamide Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Hydroxycarbamide Estimates and Projections (2016-2027)
2.4.6 India Hydroxycarbamide Estimates and Projections (2016-2027)
3 Global Hydroxycarbamide Competition Landscape by Players
3.1 Global Top Hydroxycarbamide Players by Sales (2016-2021)
3.2 Global Top Hydroxycarbamide Players by Revenue (2016-2021)
3.3 Global Hydroxycarbamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hydroxycarbamide as of 2020)
3.4 Global Hydroxycarbamide Average Price by Company (2016-2021)
3.5 Manufacturers Hydroxycarbamide Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Hydroxycarbamide Market Size by Type
4.1 Global Hydroxycarbamide Historic Market Review by Type (2016-2021)
4.1.1 Global Hydroxycarbamide Sales Market Share by Type (2016-2021)
4.1.2 Global Hydroxycarbamide Revenue Market Share by Type (2016-2021)
4.1.3 Global Hydroxycarbamide Price by Type (2016-2021)
4.2 Global Hydroxycarbamide Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Hydroxycarbamide Sales Forecast by Type (2022-2027)
4.2.2 Global Hydroxycarbamide Revenue Forecast by Type (2022-2027)
4.2.3 Global Hydroxycarbamide Price Forecast by Type (2022-2027)
5 Global Hydroxycarbamide Market Size by Application
5.1 Global Hydroxycarbamide Historic Market Review by Application (2016-2021)
5.1.1 Global Hydroxycarbamide Sales Market Share by Application (2016-2021)
5.1.2 Global Hydroxycarbamide Revenue Market Share by Application (2016-2021)
5.1.3 Global Hydroxycarbamide Price by Application (2016-2021)
5.2 Global Hydroxycarbamide Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Hydroxycarbamide Sales Forecast by Application (2022-2027)
5.2.2 Global Hydroxycarbamide Revenue Forecast by Application (2022-2027)
5.2.3 Global Hydroxycarbamide Price Forecast by Application (2022-2027)
6 North America Hydroxycarbamide Market Facts & Figures
6.1 North America Hydroxycarbamide Sales by Company
6.1.1 North America Hydroxycarbamide Sales by Company (2016-2021)
6.1.2 North America Hydroxycarbamide Revenue by Company (2016-2021)
6.2 North America Hydroxycarbamide Sales Breakdown by Type
6.2.1 North America Hydroxycarbamide Sales Breakdown by Type (2016-2021)
6.2.2 North America Hydroxycarbamide Sales Breakdown by Type (2022-2027)
6.3 North America Hydroxycarbamide Sales Breakdown by Application
6.3.1 North America Hydroxycarbamide Sales Breakdown by Application (2016-2021)
6.3.2 North America Hydroxycarbamide Sales Breakdown by Application (2022-2027)
7 Europe Hydroxycarbamide Market Facts & Figures
7.1 Europe Hydroxycarbamide Sales by Company
7.1.1 Europe Hydroxycarbamide Sales by Company (2016-2021)
7.1.2 Europe Hydroxycarbamide Revenue by Company (2016-2021)
7.2 Europe Hydroxycarbamide Sales Breakdown by Type
7.2.1 Europe Hydroxycarbamide Sales Breakdown by Type (2016-2021)
7.2.2 Europe Hydroxycarbamide Sales Breakdown by Type (2022-2027)
7.3 Europe Hydroxycarbamide Sales Breakdown by Application
7.3.1 Europe 149 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 149 Sales Breakdown by Application (2022-2027)
8 China Hydroxycarbamide Market Facts & Figures
8.1 China Hydroxycarbamide Sales by Company
8.1.1 China Hydroxycarbamide Sales by Company (2016-2021)
8.1.2 China Hydroxycarbamide Revenue by Company (2016-2021)
8.2 China Hydroxycarbamide Sales Breakdown by Type
8.2.1 China Hydroxycarbamide Sales Breakdown by Type (2016-2021)
8.2.2 China Hydroxycarbamide Sales Breakdown by Type (2022-2027)
8.3 China Hydroxycarbamide Sales Breakdown by Application
8.3.1 China 313 Sales Breakdown by Application (2016-2021)
8.3.2 China 313 Sales Breakdown by Application (2022-2027)
9 Japan Hydroxycarbamide Market Facts & Figures
9.1 Japan Hydroxycarbamide Sales by Company
9.1.1 Japan Hydroxycarbamide Sales by Company (2016-2021)
9.1.2 Japan Hydroxycarbamide Revenue by Company (2016-2021)
9.2 Japan Hydroxycarbamide Sales Breakdown by Type
9.2.1 Japan Hydroxycarbamide Sales Breakdown by Type (2016-2021)
9.2.2 Japan Hydroxycarbamide Sales Breakdown by Type (2022-2027)
9.3 Japan Hydroxycarbamide Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Hydroxycarbamide Market Facts & Figures
10.1 Southeast Asia Hydroxycarbamide Sales by Company
10.1.1 Southeast Asia Hydroxycarbamide Sales by Company (2016-2021)
10.1.2 Southeast Asia Hydroxycarbamide Revenue by Company (2016-2021)
10.2 Southeast Asia Hydroxycarbamide Sales Breakdown by Type
10.2.1 Southeast Asia Hydroxycarbamide Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Hydroxycarbamide Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Hydroxycarbamide Sales Breakdown by Application
10.3.1 Southeast Asia M Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia M Units Sales Breakdown by Application (2022-2027)
11 India Hydroxycarbamide Market Facts & Figures
11.1 India Hydroxycarbamide Sales by Company
11.1.1 India Hydroxycarbamide Sales by Company (2016-2021)
11.1.2 India Hydroxycarbamide Revenue by Company (2016-2021)
11.2 India Hydroxycarbamide Sales Breakdown by Type
11.2.1 India Hydroxycarbamide Sales Breakdown by Type (2016-2021)
11.2.2 India Hydroxycarbamide Sales Breakdown by Type (2022-2027)
11.3 India Hydroxycarbamide Sales Breakdown by Application
11.3.1 India Hydroxycarbamide Sales Breakdown by Application (2016-2021)
11.3.2 India Hydroxycarbamide Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Hydroxycarbamide Business
12.1 Bristol Myers Squibb
12.1.1 Bristol Myers Squibb Corporation Information
12.1.2 Bristol Myers Squibb Business Overview
12.1.3 Bristol Myers Squibb Hydroxycarbamide Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bristol Myers Squibb Hydroxycarbamide Products Offered
12.1.5 Bristol Myers Squibb Recent Development
12.2 Taj Pharma
12.2.1 Taj Pharma Corporation Information
12.2.2 Taj Pharma Business Overview
12.2.3 Taj Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Taj Pharma Hydroxycarbamide Products Offered
12.2.5 Taj Pharma Recent Development
12.3 Beijing Jialin Pharma
12.3.1 Beijing Jialin Pharma Corporation Information
12.3.2 Beijing Jialin Pharma Business Overview
12.3.3 Beijing Jialin Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Beijing Jialin Pharma Hydroxycarbamide Products Offered
12.3.5 Beijing Jialin Pharma Recent Development
12.4 Qilu Pharmaceutical
12.4.1 Qilu Pharmaceutical Corporation Information
12.4.2 Qilu Pharmaceutical Business Overview
12.4.3 Qilu Pharmaceutical Hydroxycarbamide Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Qilu Pharmaceutical Hydroxycarbamide Products Offered
12.4.5 Qilu Pharmaceutical Recent Development
12.5 Teva Pharma
12.5.1 Teva Pharma Corporation Information
12.5.2 Teva Pharma Business Overview
12.5.3 Teva Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Teva Pharma Hydroxycarbamide Products Offered
12.5.5 Teva Pharma Recent Development
12.6 Cipla
12.6.1 Cipla Corporation Information
12.6.2 Cipla Business Overview
12.6.3 Cipla Hydroxycarbamide Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Cipla Hydroxycarbamide Products Offered
12.6.5 Cipla Recent Development
12.7 Zydus Cadila
12.7.1 Zydus Cadila Corporation Information
12.7.2 Zydus Cadila Business Overview
12.7.3 Zydus Cadila Hydroxycarbamide Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Zydus Cadila Hydroxycarbamide Products Offered
12.7.5 Zydus Cadila Recent Development
12.8 United Biotech
12.8.1 United Biotech Corporation Information
12.8.2 United Biotech Business Overview
12.8.3 United Biotech Hydroxycarbamide Sales, Revenue and Gross Margin (2016-2021)
12.8.4 United Biotech Hydroxycarbamide Products Offered
12.8.5 United Biotech Recent Development
12.9 Par Pharma
12.9.1 Par Pharma Corporation Information
12.9.2 Par Pharma Business Overview
12.9.3 Par Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Par Pharma Hydroxycarbamide Products Offered
12.9.5 Par Pharma Recent Development
12.10 Khandelwal Laboratories
12.10.1 Khandelwal Laboratories Corporation Information
12.10.2 Khandelwal Laboratories Business Overview
12.10.3 Khandelwal Laboratories Hydroxycarbamide Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Khandelwal Laboratories Hydroxycarbamide Products Offered
12.10.5 Khandelwal Laboratories Recent Development
12.11 Alkem (Cytomed)
12.11.1 Alkem (Cytomed) Corporation Information
12.11.2 Alkem (Cytomed) Business Overview
12.11.3 Alkem (Cytomed) Hydroxycarbamide Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Alkem (Cytomed) Hydroxycarbamide Products Offered
12.11.5 Alkem (Cytomed) Recent Development
12.12 Samarth Pharma
12.12.1 Samarth Pharma Corporation Information
12.12.2 Samarth Pharma Business Overview
12.12.3 Samarth Pharma Hydroxycarbamide Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Samarth Pharma Hydroxycarbamide Products Offered
12.12.5 Samarth Pharma Recent Development
12.13 VHB Life Sciences
12.13.1 VHB Life Sciences Corporation Information
12.13.2 VHB Life Sciences Business Overview
12.13.3 VHB Life Sciences Hydroxycarbamide Sales, Revenue and Gross Margin (2016-2021)
12.13.4 VHB Life Sciences Hydroxycarbamide Products Offered
12.13.5 VHB Life Sciences Recent Development
13 Hydroxycarbamide Manufacturing Cost Analysis
13.1 Hydroxycarbamide Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Hydroxycarbamide
13.4 Hydroxycarbamide Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Hydroxycarbamide Distributors List
14.3 Hydroxycarbamide Customers
15 Market Dynamics
15.1 Hydroxycarbamide Market Trends
15.2 Hydroxycarbamide Drivers
15.3 Hydroxycarbamide Market Challenges
15.4 Hydroxycarbamide Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Hydroxycarbamide Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Hydroxycarbamide Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Hydroxycarbamide Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Hydroxycarbamide Sales (M Units) by Region (2016-2021)
Table 5. Global Hydroxycarbamide Sales Market Share by Region (2016-2021)
Table 6. Global Hydroxycarbamide Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Hydroxycarbamide Revenue Share by Region (2016-2021)
Table 8. Global Hydroxycarbamide Sales (M Units) Forecast by Region (2022-2027)
Table 9. Global Hydroxycarbamide Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Hydroxycarbamide Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Hydroxycarbamide Revenue Share Forecast by Region (2022-2027)
Table 12. Global Hydroxycarbamide Sales (M Units) of Key Companies (2016-2021)
Table 13. Global Hydroxycarbamide Sales Share by Company (2016-2021)
Table 14. Global Hydroxycarbamide Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Hydroxycarbamide Revenue Share by Company (2016-2021)
Table 16. Global Hydroxycarbamide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hydroxycarbamide as of 2020)
Table 17. Global Hydroxycarbamide Average Price (USD/K Unit) of Key Company (2016-2021)
Table 18. Manufacturers Hydroxycarbamide Manufacturing Sites and Area Served
Table 19. Manufacturers Hydroxycarbamide Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Hydroxycarbamide Sales (M Units) by Type (2016-2021)
Table 22. Global Hydroxycarbamide Sales Share by Type (2016-2021)
Table 23. Global Hydroxycarbamide Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Hydroxycarbamide Price (USD/K Unit) by Type (2016-2021)
Table 25. Global Hydroxycarbamide Sales Share by Type (2022-2027)
Table 26. Global Hydroxycarbamide Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Hydroxycarbamide Revenue Share by Type (2022-2027)
Table 28. Global Hydroxycarbamide Price (USD/K Unit) by Type (2022-2027)
Table 29. Global Hydroxycarbamide Sales (M Units) by Application (2016-2021)
Table 30. Global Hydroxycarbamide Sales Share by Application (2016-2021)
Table 31. Global Hydroxycarbamide Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Hydroxycarbamide Price (USD/K Unit) by Application (2016-2021)
Table 33. Global Hydroxycarbamide Sales (M Units) by Application (2022-2027)
Table 34. Global Hydroxycarbamide Sales Share by Application (2022-2027)
Table 35. Global Hydroxycarbamide Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Hydroxycarbamide Revenue Share by Application (2022-2027)
Table 37. Global Hydroxycarbamide Price (USD/K Unit) by Application (2022-2027)
Table 38. North America Hydroxycarbamide Sales (M Units) by Company (2016-2021)
Table 39. North America Hydroxycarbamide Sales Market Share by Company (2016-2021)
Table 40. North America Hydroxycarbamide Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Hydroxycarbamide Revenue Market Share by Company (2016-2021)
Table 42. North America Hydroxycarbamide Sales by Type (2016-2021) & (M Units)
Table 43. North America Hydroxycarbamide Sales Market Share by Type (2016-2021)
Table 44. North America Hydroxycarbamide Sales by Type (2022-2027) & (M Units)
Table 45. North America Hydroxycarbamide Sales Market Share by Type (2022-2027)
Table 46. North America Hydroxycarbamide Sales by Application (2016-2021) & (M Units)
Table 47. North America Hydroxycarbamide Sales Market Share by Application (2016-2021)
Table 48. North America Hydroxycarbamide Sales by Application (2022-2027) & (M Units)
Table 49. North America Hydroxycarbamide Sales Market Share by Application (2022-2027)
Table 50. Europe Hydroxycarbamide Sales (M Units) by Company (2016-2021)
Table 51. Europe Hydroxycarbamide Sales Market Share by Company (2016-2021)
Table 52. Europe Hydroxycarbamide Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Hydroxycarbamide Revenue Market Share by Company (2016-2021)
Table 54. Europe Hydroxycarbamide Sales by Type (2016-2021) & (M Units)
Table 55. Europe Hydroxycarbamide Sales Market Share by Type (2016-2021)
Table 56. Europe Hydroxycarbamide Sales by Type (2022-2027) & (M Units)
Table 57. Europe Hydroxycarbamide Sales Market Share by Type (2022-2027)
Table 58. Europe Hydroxycarbamide Sales by Application (2016-2021) & (M Units)
Table 59. Europe Hydroxycarbamide Sales Market Share by Application (2016-2021)
Table 60. Europe Hydroxycarbamide Sales by Application (2022-2027) & (M Units)
Table 61. Europe Hydroxycarbamide Sales Market Share by Application (2022-2027)
Table 62. China Hydroxycarbamide Sales (M Units) by Company (2016-2021)
Table 63. China Hydroxycarbamide Sales Market Share by Company (2016-2021)
Table 64. China Hydroxycarbamide Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Hydroxycarbamide Revenue Market Share by Company (2016-2021)
Table 66. China Hydroxycarbamide Sales by Type (2016-2021) & (M Units)
Table 67. China Hydroxycarbamide Sales Market Share by Type (2016-2021)
Table 68. China Hydroxycarbamide Sales by Type (2022-2027) & (M Units)
Table 69. China Hydroxycarbamide Sales Market Share by Type (2022-2027)
Table 70. China Hydroxycarbamide Sales by Application (2016-2021) & (M Units)
Table 71. China Hydroxycarbamide Sales Market Share by Application (2016-2021)
Table 72. China Hydroxycarbamide Sales by Application (2022-2027) & (M Units)
Table 73. China Hydroxycarbamide Sales Market Share by Application (2022-2027)
Table 74. Japan Hydroxycarbamide Sales (M Units) by Company (2016-2021)
Table 75. Japan Hydroxycarbamide Sales Market Share by Company (2016-2021)
Table 76. Japan Hydroxycarbamide Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Hydroxycarbamide Revenue Market Share by Company (2016-2021)
Table 78. Japan Hydroxycarbamide Sales by Type (2016-2021) & (M Units)
Table 79. Japan Hydroxycarbamide Sales Market Share by Type (2016-2021)
Table 80. Japan Hydroxycarbamide Sales by Type (2022-2027) & (M Units)
Table 81. Japan Hydroxycarbamide Sales Market Share by Type (2022-2027)
Table 82. Japan Hydroxycarbamide Sales by Application (2016-2021) & (M Units)
Table 83. Japan Hydroxycarbamide Sales Market Share by Application (2016-2021)
Table 84. Japan Hydroxycarbamide Sales by Application (2022-2027) & (M Units)
Table 85. Japan Hydroxycarbamide Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Hydroxycarbamide Sales (M Units) by Company (2016-2021)
Table 87. Southeast Asia Hydroxycarbamide Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Hydroxycarbamide Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Hydroxycarbamide Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Hydroxycarbamide Sales by Type (2016-2021) & (M Units)
Table 91. Southeast Asia Hydroxycarbamide Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Hydroxycarbamide Sales by Type (2022-2027) & (M Units)
Table 93. Southeast Asia Hydroxycarbamide Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Hydroxycarbamide Sales by Application (2016-2021) & (M Units)
Table 95. Southeast Asia Hydroxycarbamide Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Hydroxycarbamide Sales by Application (2022-2027) & (M Units)
Table 97. Southeast Asia Hydroxycarbamide Sales Market Share by Application (2022-2027)
Table 98. India Hydroxycarbamide Sales (M Units) by Company (2016-2021)
Table 99. India Hydroxycarbamide Sales Market Share by Company (2016-2021)
Table 100. India Hydroxycarbamide Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Hydroxycarbamide Revenue Market Share by Company (2016-2021)
Table 102. India Hydroxycarbamide Sales by Type (2016-2021) & (M Units)
Table 103. India Hydroxycarbamide Sales Market Share by Type (2016-2021)
Table 104. India Hydroxycarbamide Sales by Type (2022-2027) & (M Units)
Table 105. India Hydroxycarbamide Sales Market Share by Type (2022-2027)
Table 106. India Hydroxycarbamide Sales by Application (2016-2021) & (M Units)
Table 107. India Hydroxycarbamide Sales Market Share by Application (2016-2021)
Table 108. India Hydroxycarbamide Sales by Application (2022-2027) & (M Units)
Table 109. India Hydroxycarbamide Sales Market Share by Application (2022-2027)
Table 110. Bristol Myers Squibb Corporation Information
Table 111. Bristol Myers Squibb Description and Business Overview
Table 112. Bristol Myers Squibb Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 113. Bristol Myers Squibb Hydroxycarbamide Product
Table 114. Bristol Myers Squibb Recent Development
Table 115. Taj Pharma Corporation Information
Table 116. Taj Pharma Description and Business Overview
Table 117. Taj Pharma Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 118. Taj Pharma Hydroxycarbamide Product
Table 119. Taj Pharma Recent Development
Table 120. Beijing Jialin Pharma Corporation Information
Table 121. Beijing Jialin Pharma Description and Business Overview
Table 122. Beijing Jialin Pharma Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 123. Beijing Jialin Pharma Hydroxycarbamide Product
Table 124. Beijing Jialin Pharma Recent Development
Table 125. Qilu Pharmaceutical Corporation Information
Table 126. Qilu Pharmaceutical Description and Business Overview
Table 127. Qilu Pharmaceutical Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 128. Qilu Pharmaceutical Hydroxycarbamide Product
Table 129. Qilu Pharmaceutical Recent Development
Table 130. Teva Pharma Corporation Information
Table 131. Teva Pharma Description and Business Overview
Table 132. Teva Pharma Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 133. Teva Pharma Hydroxycarbamide Product
Table 134. Teva Pharma Recent Development
Table 135. Cipla Corporation Information
Table 136. Cipla Description and Business Overview
Table 137. Cipla Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 138. Cipla Hydroxycarbamide Product
Table 139. Cipla Recent Development
Table 140. Zydus Cadila Corporation Information
Table 141. Zydus Cadila Description and Business Overview
Table 142. Zydus Cadila Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 143. Zydus Cadila Hydroxycarbamide Product
Table 144. Zydus Cadila Recent Development
Table 145. United Biotech Corporation Information
Table 146. United Biotech Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 147. United Biotech Description and Business Overview
Table 148. United Biotech Hydroxycarbamide Product
Table 149. United Biotech Recent Development
Table 150. Par Pharma Corporation Information
Table 151. Par Pharma Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 152. Par Pharma Description and Business Overview
Table 153. Par Pharma Hydroxycarbamide Product
Table 154. Par Pharma Recent Development
Table 155. Khandelwal Laboratories Corporation Information
Table 156. Khandelwal Laboratories Description and Business Overview
Table 157. Khandelwal Laboratories Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 158. Khandelwal Laboratories Hydroxycarbamide Product
Table 159. Khandelwal Laboratories Recent Development
Table 160. Alkem (Cytomed) Corporation Information
Table 161. Alkem (Cytomed) Description and Business Overview
Table 162. Alkem (Cytomed) Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 163. Alkem (Cytomed) Hydroxycarbamide Product
Table 164. Alkem (Cytomed) Recent Development
Table 165. Samarth Pharma Corporation Information
Table 166. Samarth Pharma Description and Business Overview
Table 167. Samarth Pharma Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 168. Samarth Pharma Hydroxycarbamide Product
Table 169. Samarth Pharma Recent Development
Table 170. VHB Life Sciences Corporation Information
Table 171. VHB Life Sciences Description and Business Overview
Table 172. VHB Life Sciences Hydroxycarbamide Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2016-2021)
Table 173. VHB Life Sciences Hydroxycarbamide Product
Table 174. VHB Life Sciences Recent Development
Table 175. Production Base and Market Concentration Rate of Raw Material
Table 176. Key Suppliers of Raw Materials
Table 177. Hydroxycarbamide Distributors List
Table 178. Hydroxycarbamide Customers List
Table 179. Hydroxycarbamide Market Trends
Table 180. Hydroxycarbamide Market Drivers
Table 181. Hydroxycarbamide Market Challenges
Table 182. Hydroxycarbamide Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of Figures
Figure 1. Hydroxycarbamide Product Picture
Figure 2. Global Hydroxycarbamide Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Hydroxycarbamide Sales Market Share by Application in 2021 & 2027
Figure 6. Sickle Cell Disease Examples
Figure 7. Cancer Examples
Figure 8. Others Examples
Figure 9. Global Hydroxycarbamide Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Hydroxycarbamide Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Hydroxycarbamide Sales (M Units) Growth Rate (2016-2027)
Figure 12. Global Hydroxycarbamide Price Trends Growth Rate (2016-2027) (USD/K Unit)
Figure 13. Global Hydroxycarbamide Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Hydroxycarbamide Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Hydroxycarbamide Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Hydroxycarbamide Sales (M Units) Growth Rate (2016-2027)
Figure 17. Europe Hydroxycarbamide Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Hydroxycarbamide Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Hydroxycarbamide Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Hydroxycarbamide Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Hydroxycarbamide Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Hydroxycarbamide Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Hydroxycarbamide Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Hydroxycarbamide Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Hydroxycarbamide Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Hydroxycarbamide Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Hydroxycarbamide Players Market Share by Revenue in Hydroxycarbamide: 2016 & 2020
Figure 28. Hydroxycarbamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Hydroxycarbamide Revenue Share by Type (2016-2021)
Figure 30. Global Hydroxycarbamide Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Hydroxycarbamide Revenue Share by Application (2016-2021)
Figure 32. Global Hydroxycarbamide Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Hydroxycarbamide Sales Market Share by Type in 2020
Figure 34. North America Hydroxycarbamide Sales Market Share by Application in 2020
Figure 35. Europe Hydroxycarbamide Sales Market Share by Type in 2020
Figure 36. Europe Hydroxycarbamide Sales Market Share by Application in 2020
Figure 37. China Hydroxycarbamide Sales Market Share by Type in 2020
Figure 38. China Hydroxycarbamide Sales Market Share by Application in 2020
Figure 39. Japan Hydroxycarbamide Sales Market Share by Type in 2020
Figure 40. Japan Hydroxycarbamide Sales Market Share by Application in 2020
Figure 41. Southeast Asia Hydroxycarbamide Sales Market Share by Type in 2020
Figure 42. Southeast Asia Hydroxycarbamide Sales Market Share by Application in 2020
Figure 43. India Hydroxycarbamide Sales Market Share by Type in 2020
Figure 44. India Hydroxycarbamide Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Hydroxycarbamide
Figure 47. Manufacturing Process Analysis of Hydroxycarbamide
Figure 48. Hydroxycarbamide Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
世界の鎌状赤血球症診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Sickle Cell Disease Diagnosis Market The global Sickle Cell Disease Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…- 世界の鎌状赤血球症治療薬に伴う血管閉塞危機市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug Market The global Vaso-Occlusive Crisis Associated With Sickle Cell Disease Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-202…
- 世界の鎌状赤血球貧血検査＆スクリーニング市場規模・現状・予測（2021年-2027年） Sickle Cell Disease, an inherited blood disorder, often causes red blood cells (RBCs) to become sickle-shaped through the presence of the abnormal hemoglobin S variant. Highly rigid sickle-shaped blood may have difficulty passing through small blood vessels, blocking the normal blood flow, damaging …
- 鎌状赤血球症薬のグローバル市場調査 2019年 The global Sickle Cell Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Sickle Cell Disease Drug volume and value at global level, regional level and company level. From a global perspec…
- 鎌状赤血球症薬のグローバル市場調査 2019年 The global Sickle Cell Disease Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Sickle Cell Disease Drug volume and value at global level, regional level and company level. From a global perspec…